← Feed

u/Armaanwadhwa

3 theses · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ASSTr/pennystocksTechnical Analysisbullish
u/Armaanwadhwa · 327d ago2 prior · awaiting results

$ASST – CIO just cleared up the whole $1.35 warrant confusion

The $1.35 warrants are a source of capital inflow rather than dilution, with a one-year exercise window that eliminates near-term selling pressure. A clean capital structure and strengthened balance sheet position from warrant exercises support a future re-rating, especially once market understanding and float corrections catch up.

At post $32.80Now $28.28-13.8% since postedas of Sep 17, 4:30 PM ET
1d—
3d-23.8%
1w-18.9%
1m-32.3%
3m-46.9%
6m-51.8%
1y—
original post →
$ASSTr/pennystocksTechnical Analysisbullish
u/Armaanwadhwa · 327d ago2 prior · awaiting results

ASST – CIO just cleared up the “2.2x dilution” confusion + why the real float is way lower than people think

The CIO clarified that dilution fears are overstated because warrants (exercisable at $1.35) are not yet in-the-money and won't be exercised until stock is much higher, making current valuation underpriced. The company's actual float and market cap are lower than displayed, with potential $750M capital infusion when warrants eventually exercise, combined with chart evidence of a floor around $0.85 and accumulation pattern.

At post $32.80Now $28.28-13.8% since postedas of Sep 17, 4:30 PM ET
1d—
3d-12.2%
1w-18.9%
1m-31.1%
3m-46.9%
6m-50.6%
1y—
original post →
$BURUr/pennystocksTechnical Analysisbullish
u/Armaanwadhwa · 350d ago2 prior · awaiting results

$BURU — Deep Dive 2025 Update + Tekne Acquisition Status

Nuburu is executing a dramatic pivot from niche blue-laser supplier to a defense systems platform company through phased acquisition of Italian defense contractor Tekne. With a 3% equity stake and 80/20 U.S. JV already operational, $7.5M backlog underway, and Phase 3 targeting ~70% control in Q4 2025, successful execution could drive significant re-rating despite regulatory and integration risks.

At post $1.11Now $0.94-14.9% since postedas of Sep 17, 4:30 PM ET
original post →

End of results.